Stockscreener 앱 받기
0.3794
6.48%
-0.0263
시간 외 거래:
.41
0.0306
+8.07%
전일 마감가:
$0.4057
열려 있는:
$0.3986
하루 거래량:
830.48K
Relative Volume:
0.39
시가총액:
$71.29M
수익:
순이익/손실:
$-222.39M
주가수익비율:
-0.286
EPS:
-1.3268
순현금흐름:
$-193.40M
1주 성능:
-19.92%
1개월 성능:
-48.12%
6개월 성능:
-82.99%
1년 성능:
-83.58%
1일 변동 폭
$0.3658
$0.414
1주일 범위
$0.3658
$0.5049
52주 변동 폭
$0.3154
$3.65
Neumora Therapeutics Inc Stock (NMRA) Company Profile
명칭
Neumora Therapeutics Inc
전화
(857) 760-0900
주소
260 ARSENAL PLACE, SUITE 1, WATERTOWN
Compare NMRA vs VRTX, REGN, MRNA, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NMRA
Neumora Therapeutics Inc
|
0.3794 | 71.29M | 0 | -222.39M | -193.40M | -1.3268 |
VRTX
Vertex Pharmaceuticals Inc
|
523.93 | 132.80B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.02 | 82.88B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
200.10 | 79.89B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
873.71 | 54.94B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
377.63 | 42.72B | 5.76B | 514.49M | 1.10B | 4.4813 |
Neumora Therapeutics Inc Stock (NMRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-06-16 | 재확인 | H.C. Wainwright | Buy |
| 2026-06-16 | 재확인 | Needham | Buy |
| 2026-02-17 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2026-01-12 | 개시 | Leerink Partners | Outperform |
| 2025-12-01 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-10-27 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2025-09-16 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-04-02 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2025-03-10 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-03-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2025-03-07 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-01-02 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-11-05 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-10-01 | 개시 | H.C. Wainwright | Buy |
| 2024-07-22 | 개시 | Needham | Buy |
| 2024-07-08 | 개시 | Mizuho | Outperform |
| 2023-12-12 | 개시 | Deutsche Bank | Hold |
| 2023-10-10 | 개시 | BofA Securities | Buy |
| 2023-10-10 | 개시 | Guggenheim | Buy |
| 2023-10-10 | 개시 | JP Morgan | Overweight |
| 2023-10-10 | 개시 | RBC Capital Mkts | Outperform |
| 2023-10-10 | 개시 | Stifel | Buy |
| 2023-10-10 | 개시 | William Blair | Outperform |
모두보기
Neumora Therapeutics Inc 주식(NMRA)의 최신 뉴스
Neumora Therapeutics, Inc. (NMRA)What Are Researchers Thinking About This Stock? - MarketBeat
Neumora Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your RightsNMRA - ACCESS Newswire
What’s Behind Neumora Therapeutics (NASDAQ:NMRA) Now? - kalkinemedia.com
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
MU: Micron Technology Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
BlackRock Inc. Buys Shares of 7,791,869 Neumora Therapeutics, Inc. $NMRA - MarketBeat
Greg Tourangeau, Former Fulcrum Therapeutics Officer, to Sell 14,062 Shares Worth $54,420 - kalkinemedia.com
Insiders Sold Neumora Therapeutics Prematurely At US$2.29 With Stock Trading Higher - simplywall.st
Neumora Therapeutics, Inc. (NASDAQ:NMRA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
2,559,090 Shares in Neumora Therapeutics, Inc. $NMRA Purchased by ICONIQ Capital LLC - MarketBeat
Neumora Therapeutics COO Aurora disposes of $269,966 in stock - Investing.com India
Neumora Therapeutics COO Aurora disposes of $269,966 in stock - Investing.com
Neumora Therapeutics COO Aurora disposes of $269,966 in stock - Investing.com
Daljit Singh Aurora Sells 21,055 Shares of Neumora Therapeutics (NASDAQ:NMRA) Stock - MarketBeat
Neumora Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Aurora Daljit Singh - Moomoo
Neumora Therapeutics (NMRA) grants chair 500K stock options - Stock Titan
Neumora Therapeutics (NASDAQ: NMRA) officer plans 41,608-share sale after August trades - Stock Titan
Neumora Therapeutics (NMRA) grants CEO 500K stock options - Stock Titan
Mizuho maintains Outperform on Neumora, cuts target to $4 - scanx.trade
Neumora Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Neumora (NASDAQ: NMRA) officer plans cashless sale of 134K shares - Stock Titan
Neumora Therapeutics COO Daljit Aurora sells $431,674 in stock - Investing.com
Neumora Therapeutics COO Daljit Aurora sells $431,674 in stock By Investing.com - Investing.com South Africa
Neumora Therapeutics COO Daljit Aurora sells $431,674 in stock By Investing.com - Investing.com Nigeria
Neumora Therapeutics COO Daljit Aurora sells $431,674 in stock By Investing.com - Investing.com India
Neumora Therapeutics COO Daljit Aurora sells $431,674 in stock By Investing.com - Investing.com Canada
Neumora Therapeutics (NASDAQ:NMRA) Insider Daljit Singh Aurora Sells 31,000 Shares - MarketBeat
Neumora Therapeutics (NASDAQ:NMRA) Insider Daljit Singh Aurora Sells 34,987 Shares - MarketBeat
Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Aurora Daljit Singh - Moomoo
Neumora Therapeutics (NMRA) insider plans new stock sale after $329K in recent trades - Stock Titan
Q3 EPS Estimate for Neumora Therapeutics Lifted by Analyst - MarketBeat
Neumora Therapeutics, Inc. Stock 12‑Month Price Target Raised to $6.67, Implies 307% Upside - TradingView
Neumora Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Neumora (NASDAQ: NMRA) insider to sell 69K more shares - Stock Titan
Neumora Therapeutics, Inc. (NMRA) Receives a Buy from RBC Capital - The Globe and Mail
Neumora Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Neumora Therapeutics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Neumora (NASDAQ: NMRA) to sell 146K shares via Merrill Lynch - Stock Titan
Mizuho Securities Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Maintains Target Price $4 - Moomoo
H.C. Wainwright Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Maintains Target Price $7 - Moomoo
1,849,445 Shares in Neumora Therapeutics, Inc. $NMRA Purchased by Johnson & Johnson - MarketBeat
RBC Capital maintains Outperform on Neumora, cuts target to $5 - scanx.trade
Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), Celcuity (CELC) and Parabilis Medicines, Inc. (PBLS) - The Globe and Mail
Neumora Therapeutics (NASDAQ:NMRA) Upgraded at Wall Street Zen - MarketBeat
Neumora Therapeutics (NASDAQ:NMRA) Announces Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Neumora Therapeutics Releases Q2 2026 Financial Results - AlphaStreet
8-K: Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updatemoomoo - moomoo.com
Neumora Therapeutics Appoints Joshua Pinto as CEO and Releases Q2 2026 Financial Results - Kalkine Media
Neumora Therapeutics Cuts Q2 Net Loss to $41.3M on Lower R&D Spend - Minichart
Neumora Therapeutics Inc (NMRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Neumora Therapeutics Inc 주식 (NMRA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Aurora Daljit Singh | See Remarks |
Aug 21 '26 |
Sale |
1.60 |
21,055 |
33,600 |
0 |
| Aurora Daljit Singh | See Remarks |
Aug 21 '26 |
Option Exercise |
0.72 |
20,553 |
14,798 |
69,303 |
| Aurora Daljit Singh | See Remarks |
Aug 21 '26 |
Option Exercise |
0.72 |
21,055 |
15,160 |
21,055 |
| Aurora Daljit Singh | See Remarks |
Aug 21 '26 |
Sale |
1.59 |
20,553 |
32,780 |
48,750 |
| Aurora Daljit Singh | Officer |
Aug 21 '26 |
Proposed Sale |
1.60 |
41,608 |
66,380 |
0 |
| Aurora Daljit Singh | See Remarks |
Aug 20 '26 |
Option Exercise |
0.72 |
66,711 |
48,032 |
66,711 |
| Aurora Daljit Singh | See Remarks |
Aug 20 '26 |
Sale |
1.51 |
66,711 |
101,000 |
0 |
| Aurora Daljit Singh | Officer |
Aug 20 '26 |
Proposed Sale |
1.51 |
134,452 |
203,584 |
0 |
| Aurora Daljit Singh | See Remarks |
Aug 20 '26 |
Sale |
1.51 |
67,741 |
102,587 |
48,750 |
| Aurora Daljit Singh | Officer |
Aug 19 '26 |
Proposed Sale |
1.65 |
61,918 |
101,917 |
0 |
3.09%
0.72%
자본화:
|
볼륨(24시간):